Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001008322-17-000005
Filing Date
2017-02-06
Accepted
2017-02-06 10:12:14
Documents
1
Group Members
HSMITH@TSWINVEST.COMJTHOMPSON@TSWINVEST.COMLANDERSON@TSWINVEST.COM

Document Format Files

Seq Description Document Type Size
1 13G/A tsw13ganik123116.txt SC 13G/A 12069
  Complete submission text file 0001008322-17-000005.txt   13982
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Subject) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45573 | Film No.: 17574287
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 6641 WEST BROAD STREET SUITE 600 RICHMOND VA 23230
Business Address 6641 WEST BROAD STREET SUITE 600 RICHMOND VA 23230 8043534500
THOMPSON SIEGEL & WALMSLEY LLC (Filed by) CIK: 0001008322 (see all company filings)

EIN.: 540854396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A